Imprimis Pharma (NASDAQ: IMMY) reported Q2 EPS of ($0.35), versus ($0.39) reported last year. Revenue for the quarter came in at $4.9 million, versus $1.97 million reported last year.

For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.